Transitioning into GMP-Compliance: Alternative Methods for Producing Retinal Organoids for Transplantation.

ABSTRACT:

Translational relevance

Designing a GMP-compliant protocol for three-dimensional retinal organoid production is of urgent need in order to bring transplantation of hiPSC-derived retinal tissue and derived cells to clinical trials - and ultimately patient treatment - for retinal degenerative diseases.

SUBMITTER: Cobb H 

PROVIDER: S-EPMC8362632 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature